Breaks Categories: News

ThursdayMar 05, 2020 11:47 am

NetworkNewsBreaks – Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) Featured in Mizuho Securities Research Report

Concert Pharmaceuticals, Inc.  (NASDAQ: CNCE) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Concert reported 4Q19/FY19 results yesterday. 4Q19 EPS was $(0.86) compared to FactSet consensus of $(0.79) while FY19 EPS was $(3.29) vs. consensus of $(3.22). We do not see earnings as the most important value driver for pre-commercial stage biotechs. Importantly, the company continues to make progress on the clinical development front with CTP-543, and CTP-692 - two wholly-owned assets. We continue to expect that the Phase 2 readouts from CTP-692 in schizophrenia expected by YE2020 could be an…

Continue Reading

ThursdayMar 05, 2020 11:39 am

NetworkNewsBreaks – Forty Seven, Inc. (NASDAQ: FTSV) Featured in Mizuho Securities Research Report

Forty Seven, Inc. (NASDAQ: FTSV) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “GILD to acquire FTSV in an all cash deal for $95.50 per share, valuing FTSV at ~$4.9 bln. The deal is expected to close 2Q20, and is subject to regulatory approvals and other customary closing conditions. We have previously written about the possibility of an acquisition or partnership in a previous note.” To request access to the full report, visit http://nnw.fm/SaZ9d About Forty Seven, Inc. Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer…

Continue Reading

ThursdayMar 05, 2020 11:26 am

NetworkNewsBreaks – Zogenix, Inc. (NASDAQ: ZGNX) Featured in Mizuho Securities Research Report

Zogenix, Inc. (NASDAQ: ZGNX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Zogenix reported earnings yesterday. 4Q19 EPS was $(1.26) vs. FactSet consensus of $(1.04) and FY19 EPS was $(9.74) vs. consensus of $(9.54). We do not see earnings as the most important value driver for ZGNX at this stage. Importantly, we remain confident in the potential FDA approval of FINTEPLA for the treatment of Dravet syndrome (PDUFA: 06/25/20). On yesterday's call, management highlighted two-year interim data showing long-term reductions in seizure frequency, supporting our view that FINTEPLA may be differentiated…

Continue Reading

ThursdayMar 05, 2020 11:18 am

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Featured in Mizuho Securities Research Report

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We get our weekly data from IQVIA, which uses a statistical methodology that requires the extrapolation of data from pharmacies that respond to weekly surveys. During a product launch, volumes can be lumpy across pharmacies which we believe makes it more difficult to extrapolate data. As such, we note that AERI publishes sales-out data on their website monthly (see here for most recent, slide 8), which provides a more complete picture of their weekly sales data.” To request…

Continue Reading

ThursdayMar 05, 2020 11:15 am

NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Exhibit at HIMSS 2020 Global Health Conference & Exhibition

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables drug availability, care services and price transparency for both pharmacists and consumers, today announced that it will exhibit at HIMSS 2020. The event, which will draw over 45,000 healthcare professionals, is slated to take place at the Orange County Convention center in Orlando, Florida from March 9-13. Trxade’s booth will be located in Exhibit Hall E, Booth (#7273), Kiosk (#13). Members from the company’s leadership team will be present and provide detailed DEMO and information on products including: DelivMeds and Bonum Health, demonstrating the latest advances…

Continue Reading

ThursdayMar 05, 2020 11:10 am

NetworkNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Lead Researcher Behind its Diabetes Gene Therapy Featured in New Video Interview

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, today announced that Dr. George Gittes, the lead researcher and Harvard graduate that developed Genprex’s new potentially curative diabetes gene therapy, was featured in a video interview discussing the therapy. According to the update, Dr. Gittes joined one of Proactive’s broadcast journalists to provide an overview of the gene therapy, how it works, how it may have the potential to help treat type 1 and type 2 diabetes, as well as next steps to move the gene therapy to the clinic. “We…

Continue Reading

ThursdayMar 05, 2020 10:31 am

NetworkNewsBreaks – Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) to be Profiled on Business TV-News in US, Canada

Exro Technologies (CSE: XRO) (OTCQB: EXROF) today announced that its technology to improve the performance of the world's electric motors will be profiled on Business TV-News, first airing this weekend in Canada on the BNN Bloomberg network. According to the update, Exro's CEO Sue Ozdemir will appear and provide an overview of the company’s technology to dramatically improve the speed, torque and energy efficiency of electric motors. The broadcast will air in Canada on Saturday, March 7, and in the U.S. on March 15. “Our objective is to tell investors, manufacturers and the public around the world about our remarkable…

Continue Reading

ThursdayMar 05, 2020 10:00 am

NetworkNewsBreaks – OriginClear Inc. (OCLN) Announces Disruptive Pricing of Pump and Lift Systems to Undercut Conventional, Pre-Cast Concrete Stations

OriginClear (OTCQB: OCLN), a leading provider of water treatment solutions, today announced a major repricing of its Modular Water Systems Pump and Lift Stations. According to the update, these systems, constructed using Structural Reinforced Thermoplastics (“SRTP”) with a lifespan of up to 100 years, are now priced to undercut conventional, pre-cast concrete stations, while maintaining profitability. “The key was standardization,” OriginClear CEO Riggs Eckelberry said in the news release. “Recently we made the breakthrough of eliminating all engineering design charges, after learning from nearly half a million dollars in custom sales. Our goal is to deliver disruptive water industry technology…

Continue Reading

ThursdayMar 05, 2020 9:32 am

NetworkNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Enters Joint Sales Agreement with Materialise NV (NASDAQ: MTLS) to Commercialize Integrated PrintRite3D Technology with MCP Controller

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has entered into a binding joint sales agreement with Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services. Per the update, the companies have agreed to advance the previously announced memorandum of understanding (“MOU”) to work together to integrate the Materialise Control Platform (“MCP”) product with Sigma Labs' PrintRite3D(R) technology. Through the joint sales agreement, the companies have agreed to carry out beta customer commercialization of the integrated PrintRite3D(R) and Materialise…

Continue Reading

ThursdayMar 05, 2020 9:00 am

NetworkNewsBreaks – NeoVolta Inc. (NEOV) Poised to Profit from Projected Surge in Home Solar Battery Sales

BloombergNEF, Bloomberg’s research service, recently predicted that a minimum of 50,000 California homes will install storage systems in 2020 (http://nnw.fm/OJ75s). BloombergNEF attributes this anticipated surge in demand to the extensive and prolonged blackouts in 2019, which resulted in many California solar customers to add storage batteries as a source of backup power. NeoVolta (OTCQB: NEOV) is prepared to meet the projected demand for storage with its NV14 storage system. The high-performance, competitively priced systems can connect with any residential solar installation, including new, existing, AC or DC. “Solar storage offers a host of advantages for homeowners, and experts agree that…

Continue Reading